Evaluation of the in vitro antiretroviral potential of some Biginelli-type pyrimidines

Acta Virologica

Volumn 56, Issue 1, 2012, Pages 11-18

  Zabihollahi, R ^a   Vahabpour, R ^b   Hartoonian, C ^b   Sedaghati, B ^a   Sadat, S M ^b   Soleymani, M ^c   Ranjbar, M ^c   Fassihi, A ^a   Aghasadeghi, M R ^b   Memarian, H R ^c   Salehi, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Antivirals; Biginelli type pyrimidines; HIV 1

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PYRIMIDINE DERIVATIVE; GREEN FLUORESCENT PROTEIN; LUCIFERASE;

ANTIVIRAL ACTIVITY; ARTICLE; BIGINELLI REACTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MURINE LEUKEMIA VIRUS; NONHUMAN; STRUCTURE ACTIVITY RELATION; SYNCYTIUM; VIRUS REPLICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; CELL LINE; CELL SURVIVAL; DOG; DRUG EFFECT; GENETICS; GIANT CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN; IC 50; PHYSIOLOGY; REPORTER GENE; SYNTHESIS; T LYMPHOCYTE; THYMOCYTE; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-HIV AGENTS; CELL LINE; CELL SURVIVAL; DOGS; GENES, REPORTER; GIANT CELLS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; LUCIFERASES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; THYMOCYTES; VIRUS REPLICATION;

EID: 84862245323     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2012_01_11     Document Type: Article

References (46)

1. Alkhatib G, Broder CC, Berger EA (1996): Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J. Virol. 70, 5487-5494.
2. Ashok M, Holla BS, Kumari NS (2007): Convenient one pot synthesis of some novel derivatives of thiazolo[2,3-b] dihydropyrimidinone possessing 4-methylthiophenyl moiety and evaluation of their antibacterial and antifungal activities. Eur. J. Med. Chem. 42, 380-385. http://dx.doi.org/10.1016/j.ejmech.2006.09.003
3. Bahekar SS, Shinde DB (2004): Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivatives. Bioorg. Med. Chem. Lett. 14, 1733-1736. http://dx.doi.org/10.1016/j.bmcl.2004.01.039
4. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983): Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871. http://dx.doi.org/10.1126/science.6189183
5. Barreca ML, Ferro S, Rao A, De Luca L, Zappala M, Monforte AM, Debyser Z, Witvrouw M, Chimirri A. (2005): Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors. J. Med. Chem. 48, 7084-7088. http://dx.doi.org/10.1021/jm050549e
6. Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C (2000): In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. J. Med. Chem. 43, 2703-2718. http://dx.doi.org/10.1021/jm990612y
7. Bartz SR, Emerman M (1999): Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J. Virol. 73, 1956-1963.
8. Besoluk S, Kucukislamoglu M, Nebioglu M, Zengin M, Arslan M (2008): Solvent-free synthesis of dihydropyrimidinones catalyzed by alumina sulfuric acid at room temperature. J. Iran Chem. Soc. 5, 62-66.
9. Biginelli P (1893): Aldehyde-urea derivatives of aceto-and oxaloacetic acids. Gaz. Chim. Ital. 23, 360-413.
10. Campbell EM, Perez O, Melar M, Hope TJ (2007): Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 360, 286-293. http://dx.doi.org/10.1016/j.virol.2006.10.025
11. Cao J, Park IW, Cooper A, Sodroski J (1996): Molecular determinants of acute single-cell lysis by human immunodefi-ciency virus type 1. J. Virol. 70, 1340-1354.
12. Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC (2004): HIV-1 virion fusion assay: uncoating not required and no eff ect of Nef on fusion. Virology 328, 36-44. http://dx.doi.org/10.1016/j.virol.2004.07.015
13. Chen M, Elder RT, Yu M, O'Gorman MG, Selig L, Benarous R, Yamamoto A, Zhao Y (1999): Mutational analysis of Vprinduced G2 arrest, nuclear localization, and cell death in fission yeast. J. Virol. 73, 3236-3245.
14. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996): The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148. http://dx.doi.org/10.1016/S0092-8674(00)81313-6
15. Cook PR (1993): A model for reverse transcription by a dimeric enzyme. J. Gen. Virol. 74, 691-697. http://dx.doi.org/10.1099/0022-1317-74-4-691
16. Dedera D, Ratner L (1991): Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J. Virol. 65, 6129-6136.
17. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996): HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673. http://dx.doi.org/10.1038/381667a0
18. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP (1984): NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Intern. Med. 100, 92-106.
19. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO (2002): Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 288, 181-188. http://dx.doi.org/10.1001/jama.288.2.181
20. Hurst EW (1962): Experimental chemotherapy of infection with agents of the psittacosis-lymphogranuloma-trachoma group. Ann. NY Acad. Sci. 98, 275-286. http://dx.doi.org/10.1111/j.1749-6632.1962.tb30551.x
21. Hurst EW, Hull R (1961): Two new synthetic substances active against viruses of the psittacosis-lymphogranulomatrachoma group. J. Med. Pharm. Chem. 3, 215-229. http://dx.doi.org/10.1021/jm50015a002
22. Imamichi T (2004): Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors. Curr. Pharm. Des. 10, 4039-4053. http://dx.doi.org/10.2174/1381612043382440
23. Jiang C, You QD (2007): An efficient and solvent-free one-pot synthesis of dihydropyrimidinones under microwave irradiation. Chinese Chem. Lett. 18, 647-650. http://dx.doi.org/10.1016/j.cclet.2007.04.002
24. Kappe CO (2000): Biologically active dihydropyrimidones of the Biginelli-type-a literature survey. Eur. J. Med. Chem. 35, 1043-1052. http://dx.doi.org/10.1016/S0223-5234(00)01189-2
25. Klein E, DeBonis S, Thiede B, Skoufias DA, Kozielski F, Lebeau L. (2007): New chemical tools for investigating human mitotic kinesin Eg5. Bioorg. Med. Chem. 15, 6474-6488. http://dx.doi.org/10.1016/j.bmc.2007.06.016
26. Kumar D, Mishra BG, Rao VS (2006): An environmentally benign protocol for the synthesis of 3,4-dihydropyrimidine-2(1H)-ones using solid acid catalysts under solvent-free conditions. Indian J. Chem. 45, 2325-2329.
27. LaBonte JA, Madani N, Sodroski J (2003): Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4+ expression. J. Virol. 77, 6645-6659. http://dx.doi.org/10.1128/JVI.77.12.6645-6659.2003
28. Lin PF, Blair W, Wang T, Spicer T, Guo Q, Zhou N, Gong YF, Wang HG, Rose R, Yamanaka G, Robinson B, Li CB, Fridell R, Deminie C, Demers G, Yang Z, Zadjura L, Meanwell N, Colonno R (2003): A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4+ receptor binding. Proc. Natl. Acad. Sci. USA 100, 11013-11018. http://dx.doi.org/10.1073/pnas.1832214100
29. Lu J, Bai YJ, Wang ZJ, Ma HR (2002): CoC12 6H2O or LaCl3 7H2O catalyzed Biginelli reaction. One-pot synthesis of 3 4-dihydropyrimidin-2(1H)-ones. Chinese Chem. Lett. 20, 681-687.
30. Madani N, Hubicki AM, Perdigoto AL, Springer M, Sodroski J (2007): Inhibition of human immunodeficiency virus envelope glycoprotein-mediated single cell lysis by lowmolecular-weight antagonists of viral entry. J. Virol. 81, 532-538. http://dx.doi.org/10.1128/JVI.01079-06
31. McCloskey TW, Ott M, Tribble E, Khan SA, Teichberg S, Paul MO, Pahwa S, Verdin E, Chirmule N (1997): Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158, 1014-1019.
32. Obiako OR, Murktar HM, Ogoina D (2010): Antiretroviral drug resistance-implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries. Niger J. Med. 19, 302-310.
33. Okada H, Takei R, Tashiro M (1997): HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas). FEBS Lett. 414, 603-606. http://dx.doi.org/10.1016/S0014-5793(97)01080-6
34. Patil CW, Kumar NV, Kokke WC, Bean MF, Freyer AJ, Debrossi C, Mai S, Trunch A, Faulkner DJ, Carte B, Breen AL, Hertzberg RP, Johnson RK, Westley JW (1995): Potts BCM. Novel alkaloids from the Sponge Batzella sp.: Inhibitors of HIV gp120-Human CD4 Binding. J. Org. Chem. 60, 1182-1188. http://dx.doi.org/10.1021/jo00110a021
35. Rasola A, Gramaglia D, Boccaccio C, Comoglio PM (2001): Apoptosis enhancement by the HIV-1 Nef protein. J. Immunol. 166, 81-88.
36. Rovnyak GC, Atwal KS, Hedberg A, Kimball SD, Moreland S, Gougoutas JZ, O'Reilly BC, Schwartz J, Malley MF (1992): Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents. J. Med. Chem. 35, 3254-3263. http://dx.doi.org/10.1021/jm00095a023
37. Russowsky D, Lopes FA, da SV, Canto KFS, D'Oca MGM, Godoi MN. (2004): Multicomponent Biginelli's synthesis of 3,4-dihydropyrimidin-2(1H)-ones promoted by SnCl2.2H2O. J. Braz. Chem. Soc. 15, 165-169. http://dx.doi.org/10.1590/S0103-50532004000200002
38. Sadat SM, Zabihollahi R, Aghasadeghi MR, Vahabpour R, Siadat SD, Memarnejadian A, Azadmanesh K, Parivar K (2011): Application of SCR priming VLP boosting as a novel vaccination strategy against HIV-1. Curr. HIV Res. 9, 140-147. http://dx.doi.org/10.2174/157016211795945223
39. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF (2003): Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727-728. http://dx.doi.org/10.1038/nm880
40. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA (1986): Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322, 470-474. http://dx.doi.org/10.1038/322470a0
41. Soleymani M, Memarian HR (2010): Synthesis of 3,4-dihydropyrimidin-2(1H)-one-5-carboxamides. Z. Naturforsch. 65, 485-492.
42. Stefani HA, Oliveira CB, Almeida RB, Pereira CM, Braga RC, Cella R, Borges VC, Savegnago L, Nogueira CW (2006): Dihydropyrimidin-(2H)-ones obtained by ultrasound irradiation: a new class of potential antioxidant agents. Eur. J. Med. Chem. 41, 513-518. http://dx.doi.org/10.1016/j.ejmech.2006.01.007
43. Tan JJ, Cong XJ, Hu LM, Wang CX, Jia L, Liang XJ (2010): Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection. Drug Discov. Today 15, 186-197. http://dx.doi.org/10.1016/j.drudis.2010.01.004
44. Wilkin TJ, Shalev N, Tieu HV, Hammer SM (2010): Advances in antiretroviral therapy. Top. HIV Med. 18, 66-92.
45. Zabihollahi R, Sadat SM, Vahabpour R, Aghasadeghi MR, Memarnejadian A, Ghazanfari T, Salehi M, Rezaei A, Azadmanesh K (2011): Development of single-cycle replicable human immunodeficiency virus 1 mutants. Acta Virol. 55, 15-22. http://dx.doi.org/10.4149/av_2011_01_15
46. Zhan HW, Wang JX, Wang XT (2008): Solvent-and catalyst-free synthesis of dihydropyrimidinthiones in one-pot under focused microwave irradiation conditions. Chinese Chem. Lett. 19, 1183-1185. http://dx.doi.org/10.1016/j.cclet.2008.06.039